Philippe Rouanet

Breast-Conserving Treatment With or Without Radiotherapy in Ductal Carcinoma-In-Situ: Ten-Year Results of European Organisation for Research and Treatment of Cancer Randomized Phase III Trial 10853—A Study by the EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group

Nina Bijker, Philip Meijnen, Johannes L. Peterse et al. · Journal of Clinical Oncology · 2006 · 657 citations

Radiotherapy in breast-conserving treatment for ductal carcinoma in situ: first results of the EORTC randomised phase III trial 10853

Jean‐Pierre Julien, Nina Bijker, Ian S. Fentiman et al. · The Lancet · 2000 · 510 citations

Surgical Oncology, Radiation Therapy, Medicine +10

Effect of Interval (7 or 11 weeks) Between Neoadjuvant Radiochemotherapy and Surgery on Complete Pathologic Response in Rectal Cancer: A Multicenter, Randomized, Controlled Trial (GRECCAR-6)

Jérémie H. Lefèvre, Laurent Mineur, Salma Kotti et al. · Journal of Clinical Oncology · 2016 · 462 citations

Rectal Tumor, Surgical Oncology, Health Sciences +15

Breast-Conserving Treatment With or Without Radiotherapy in Ductal Carcinoma In Situ: 15-Year Recurrence Rates and Outcome After a Recurrence, From the EORTC 10853 Randomized Phase III Trial

Mila Donker, Saskia Litière, Gustavo Werutsky et al. · Journal of Clinical Oncology · 2013 · 371 citations · Full text

Organ preservation for rectal cancer (GRECCAR 2): a prospective, randomised, open-label, multicentre, phase 3 trial

Éric Rullier, Philippe Rouanet, Jean‐Jacques Tuech et al. · The Lancet · 2017 · 366 citations

Gastrointestinal Oncology, Greccar 2, Colorectal Surgery +8